A rapid and simple CYP2D6 genotyping assay—case study with the analgetic tramadol
- 1 November 2003
- journal article
- clinical trial
- Published by Elsevier in Metabolism
- Vol. 52 (11) , 1439-1443
- https://doi.org/10.1016/s0026-0495(03)00256-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Concordance between tramadol and dextromethorphan parent/metabolite ratios: the influence of CYP2D6 and non-CYP2D6 pathways on biotransformation.The Journal of Clinical Pharmacology, 2002
- Anticonvulsant and proconvulsant effects of tramadol, its enantiomers and its M1 metabolite in the rat kindling model of epilepsyBritish Journal of Pharmacology, 2000
- Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatmentPharmacogenomics, 2000
- Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genesPharmacogenetics and Genomics, 1999
- Ultrarapid metabolism of sparteinePharmacogenetics, 1998
- Rapid detection of CYP2D6 null alleles by long distance-and multiplex-polymerase chain reactionPharmacogenetics, 1996
- An efficient strategy for detection of known and new mutations of the CYP2D6 gene using single strand conformation polymorphism analysisPharmacogenetics, 1995
- pNAT and CYP2D6 gene polymorphism in epileptic patientsBiochemical Pharmacology, 1994
- [17] Genetic polymorphism of debrisoquine oxidation: restriction fragment analysis and allele-specific amplification of mutant alleles of CYP2D6Published by Elsevier ,1991
- Identification of the primary gene defect at the cytochrome P450 CYP2D locusNature, 1990